Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01959035 · ClinicalTrials.gov registry record · Phase 3
Aripiprazole Once-monthly in Patients With Schizophrenia
A Phase 3 study, sponsored by H. Lundbeck A/S.
- Completed
- Registry status
- Phase 3
- Development phase
- 88
- Enrollment target
NCT01959035: Completed Phase 3 study, sponsored by H. Lundbeck A/S.
NCT01959035 is a Phase 3 study that has completed, run by H. Lundbeck A/S. The registered enrollment target is 88 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01959035, a Phase 3 study, has completed, sponsored by H. Lundbeck A/S.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 88 participants
- Enrollment target
Study Summary
To obtain information on the safety, tolerability and effectiveness of aripiprazole once-monthly in a manner consistent with its intended use in everyday clinical practice in patients with schizophrenia who completed Study 14724A / NCT01795547.
Primary Outcome
Number of treatment emergent adverse events (TEAEs).
Interventions
- DRUG Aripiprazole once-monthly
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-03 |
| Phase | Phase 3 |
What the finished NCT01959035 record still lists
NCT01959035 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Aripiprazole once-monthly is the first listed.
NCT01959035 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01959035 about?
NCT01959035 is a clinical study titled "Aripiprazole Once-monthly in Patients With Schizophrenia". To obtain information on the safety, tolerability and effectiveness of aripiprazole once-monthly in a manner consistent with its intended use in everyday clinical practice in patients with schizophrenia who completed Study 14724A / NCT01795547.
What is the current status of trial NCT01959035?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 88 participants. The study started on 2013-10. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01959035?
The interventions under investigation include: Aripiprazole once-monthly (DRUG).
Who is sponsoring clinical trial NCT01959035?
This trial is sponsored by H. Lundbeck A/S, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01959035's enrollment target sits among peer trials
88 1739th of 2000 higher than 259 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia